Abstract:Tumor cells are rich in antigens, which provide a reliable antigen library for the design of personalized vaccines. However, an effective tumor vaccine vector that can efficiently deliver antigens to lymphoid organs to stimulate strong CD8+ cytotoxic T-lymphocyte immune response is still lacking. Here we designed a dual-antigen delivery system based on hepatitis B virus core antigen virus-like particles (HBc VLPs). We first confirmed that different antigen-loaded HBc VLP monomers could be assembled into nanoparticles (hybrid VLPs). Hybrid VLPs could slightly enhance bone marrow-derived dendritic cell maturation in vitro. Strikingly, hybrid VLPs could generate antigen-specific antitumor immunity and innate immunity in vivo which could significantly inhibit tumor growth or metastatic formation in a subcutaneous tumor or lung metastatic tumor model, respectively. Moreover, dual-epitope vaccination generated enhanced T-cell responses that potently inhibited tumor growth and metastatic formation. Together, this study provides a new powerful concept for cancer immunotherapy and suggests a novel design for VLP-based personalized nanomedicine.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acsami.0c16012?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acsami.0c16012</a>.SDS-PAGE of purified HBc-OVA VLPs and HBc-gp100 VLPs, western blot analysis, TEM images and size distribution of HBc-gp100 VLPs and HBc-OVA VLPs, molecular weight characterization, TEM images of fresh hybrid VLPs and hybrid VLPs after incubation in 10% FBS for 24 h, cytotoxicity of antigen-loaded HBc VLPs, in vitro imaging of the HBc-VLP nanoprobes, DC maturation induced by the indicated formulations in BMDCs, biodistribution of Cy5.5-OVA257–264 and Cy5.5-hybrid VLPs, evaluation of innate immune response induced by HBc VLPs, flow cytometry plots of CFSE-labeled CD3+ cells, biosafety evaluation of HBc VLPs, evaluation of antigen-specific immune response induced by antigen-loaded HBc VLPs, evaluation of inflammatory cytokines, and representative flow cytometry plots showing different groups of CD3+CD8+ T cells in the lymph nodes (<a class="ext-link" href="/doi/suppl/10.1021/acsami.0c16012/suppl_file/am0c16012_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Bacterial Vesicle-Cancer Cell Hybrid Membrane-Coated Nanoparticles for Tumor Specific Immune Activation and Photothermal Therapy

Biomimetic Metallacage Nanoparticles with Aggregation-Induced Emission for NIR-II Fluorescence Imaging-Guided Synergistic Immuno-Phototherapy of Tumors

Cancer Cell Membrane-Coated Nanoparticles for Anticancer Vaccination and Drug Delivery

Near‐Infrared Responsive Membrane Nanovesicles Amplify Homologous Targeting Delivery of Anti‐PD Immunotherapy Against Metastatic Tumors

&Lt;p>cell Membrane Camouflaged Nanoparticles: a New Biomimetic Platform for Cancer Photothermal Therapy</p>

Tumor-Associated-Macrophage-Membrane-Coated Nanoparticles for Improved Photodynamic Immunotherapy

Immunogenic Hybrid Nanovesicles of Liposomes and Tumor-Derived Nanovesicles for Cancer Immunochemotherapy

Bacteria-derived Membrane Vesicles to Advance Targeted Photothermal Tumor Ablation

B16 Membrane-Coated Vesicles for Combined Photodynamic Therapy and Immunotherapy Shift Immune Microenvironment of Melanoma

Phytochemical Engineered Bacterial Outer Membrane Vesicles for Photodynamic Effects Promoted Immunotherapy.

Surface Mineralization of Engineered Bacterial Outer Membrane Vesicles to Enhance Tumor Photothermal/Immunotherapy

Hybrid Vesicles Based on Autologous Tumor Cell Membrane and Bacterial Outer Membrane To Enhance Innate Immune Response and Personalized Tumor Immunotherapy

Engineered bacterial membrane vesicle as safe and efficient nano-heaters to reprogram tumor microenvironment for enhanced immunotherapy

Cancer cell membrane-coated nanoparticles for bimodal imaging-guided photothermal therapy and docetaxel-enhanced immunotherapy against cancer

Natural Killer Cell Membrane Doped Supramolecular Nanoplatform with Immuno-Modulatory Functions for Immuno-Enhanced Tumor Phototherapy

Bacterial outer membrane vesicle-templated biomimetic nanoparticles for synergistic photothermo-immunotherapy

Redirecting Antigens by Engineered Photosynthetic Bacteria and Derived Outer Membrane Vesicles for Enhanced Cancer Immunotherapy

A Hybrid Eukaryotic–Prokaryotic Nanoplatform with Photothermal Modality for Enhanced Antitumor Vaccination

Erythrocyte-Cancer Hybrid Membrane Camouflaged Hollow Copper Sulfide Nanoparticles for Prolonged Circulation Life and Homotypic-Targeting Photothermal/Chemotherapy of Melanoma

Cancer Cell Membrane Camouflaged Biomimetic Nanosheets for Enhanced Chemo-Photothermal-starvation Therapy and Tumor Microenvironment Remodeling

Dual-Antigen-Loaded Hepatitis B Virus Core Antigen Virus-like Particles Stimulate Efficient Immunotherapy Against Melanoma